Asosiy kontentga oʻtish

Mark W. Frohlich

1 ta ish

Dendreon (United States)

  1. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

    Philip W. Kantoff, Celestia S. Higano, Neal D. Shore +10

    MaqolaOchiq kirish20103 iqtibos
    ABI